RecruitingNot ApplicableNCT06250699

A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery

A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery Through Tubeless Laparoscopic Adrenalectomy


Sponsor

Zhe Meng

Enrollment

200 participants

Start Date

Jan 3, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to exploring the role of tubeless after adrenalectomy surgery. The main questions it aims to answer are: 1. The safety of tubeless laparoscopic adrenalectomy; 2. The role of tubeless therapy in rapid recovery after adrenalectomy surgery Participants will be randomly divided into two groups: the non drainage group and the drainage group after laparoscopic adrenal surgery, and their pain, first time out of bed, and intestinal recovery time will be observed.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria2

  • According to the 2022 edition of the Chinese Guidelines for Diagnosis and Treatment of Urological Diseases, patients who meet the surgical indications
  • The patient has signed an informed consent form before joining the clinical trial, and the age at the time of signing the informed consent form is 18-70 years old.

Exclusion Criteria4

  • Patients with complications that seriously affect treatment or quality of life
  • The patient has any physical condition that the researcher believes will affect the clinical status
  • Patients who have placed vascular stents such as heart and cerebrovascular stents within the past year
  • Pregnant or lactating patients

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETubeless laparoscopic adrenalectomy

No drainage tube placed after laparoscopic adrenalectomy

PROCEDUREDrainage tube

Placing drainage tubes after laparoscopic adrenalectomy


Locations(1)

Zhongnan hospital

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06250699


Related Trials